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The Twist proteins (Twist-1 and -2) are highly conserved developmental proteins with
key roles for the transcriptional regulation in mesenchymal cell lineages. They belong
to the super-family of bHLH proteins and exhibit bi-functional roles as both activators
and repressors of gene transcription. The Twist proteins are expressed at low levels in
adult tissues but may become abundantly re-expressed in cells undergoing malignant
transformation. This observation prompted extensive research on the roles of Twist
proteins in cancer progression and metastasis. Very recent studies indicate a novel role
for Twist-1 as a potential regulator of adipose tissue (AT) remodeling and inflammation.
Several studies suggested that developmental genes are important determinants of
obesity, fat distribution and remodeling capacity of different adipose depots. Twist-1 is
abundantly and selectively expressed in the adult AT and its constitutive expression is
significantly higher in subcutaneous (SAT) vs. visceral (VAT) fat in both mice and humans.
Moreover, Twist1 expression is strongly correlated with BMI and insulin resistance in
humans. However, the functional roles and transcriptional downstream targets of Twist1
in AT are largely unexplored. The purpose of this review is to highlight the major findings
related to Twist1 expression in different fat depots and cellular components of AT and
to discuss the potential mechanisms suggesting a role for Twist1 in AT metabolism,
inflammation and remodeling.
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REGULATION OF GENE TRANSCRIPTION BY Twist1
The transcriptional regulatory outcomes of Twist1 are dictated
by several factors that include spatial and temporal cellular
expression, protein–protein interactions, binding partner speci-
ficity, and post-transcriptional regulation by phosphorylation
(Figure 1).
Twist1 has the generic modular structure of the family of
basic helix-loop-helix (bHLH) transcription factors with an
N-terminus region responsible for protein–protein interactions; a
basic HLH domain that is capable to form homo- or heterodimers
with other E-box proteins which upon dimerization recognize
and bind a canonical consensus sequence in the DNA; and, a
C-terminal region that contains the Twist box domain charac-
terized both as an activation and as a repressor domain (Thisse
et al., 1987, 1988; Murre et al., 1989; Kadesch, 1993) (Figure 1).
The accessibility and choice of the binding partners is dictated
by several mechanisms including phosphorylation state of Twist1
and accessibility of the other E-box proteins (Connerney et al.,
2006; Firulli and Conway, 2008). For example, the id class of
bHLH transcription factors can sequester binding partners for
Twist, such as E12, therefore impacting on the type of dimer and
transcriptional outcome (Benezra et al., 1990; Connerney et al.,
2006). Partner choice can also be dictated by the level of Twist1
phosphorylation. PKA, PKC, PKB/Akt, and PP2 can all deter-
mine phosphorylation levels of Twist1 at highly conserved Ser
and Thr residues in the HLH region (Firulli et al., 2003; Firulli
and Conway, 2008; Vichalkovski et al., 2010; Hong et al., 2011).
Also, the redox state of the cell can determine the transcrip-
tional outcome by formation of homodimers that are stabilized by
disulfide bonds therefore preventing formation of heterodimeric
complexes with other E-box proteins (Danciu and Whitman,
2010).
Twist1 can also influence gene expression via epigenetic mech-
anisms. Interaction of Twist1 with HATs and HDACs, for example
HDAC4, induces recruitment of the latter at the cis-regulatory
regions in DNA resulting in histone modification and repres-
sion of gene transcription (Hamamori et al., 1999; Gong and Li,
2002). Also, a recent paper showed that Twist1 directly regulates
formation of miRNA such as let-7i which results in downstream
activation of Rac1 (Yang et al., 2012). All of these potential mech-
anisms contribute to the transcriptional outcome and depend
upon the cell type and microenvironment.
Twist2 is the other member of the twist subfamily and presents
66% homology with Twist1 with over 98% homology in the
basic and HLH domains of the protein (Franco et al., 2010).
The common intron/exon organization of the two genes likely
reflects an evolutionary gene duplication event. Although, some
of the actions of Twist1 and 2 are redundant, specific tissue and
temporal expressional patterns suggest also separate roles and
mechanisms on gene regulation (Franco et al., 2010).
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FIGURE 1 | Molecular structure of the human Twist protein.
Twist1 has the typical modular structure of the basic helix-loop-helix
(bHLH) transcription factor family. At the N-terminus region 2 nuclear
localization signals (NLS) are located at positions 37–40 and 73–77,
respectively. The protein–protein interactions are delineated with black bars
on top; PCAF = p300/CBP associated factor; CPB = cAMP response
element binding protein; binding of the partner proteins in this region
inhibits recruitment of the histone remodeling proteins HDAC (histone
de-acetylase) and HAT (histone acetyl transferase). Twist1 can form
heterodimers with other bHLH transcription factors that subsequently bind
to the consensus E-box sequences in target genes. Some of the binding
partners are the universal E-box proteins E12 and E47; also, Myo D
involved in muscle differentiation; Id family of proteins can sequester the
E-box transcription factors and therefore prevent formation of the dimers
with Twist1. In the C-terminal region, the functional Twist box domain can
bind Runx 2 or 3 (runt transcription factors). A number of functional
Ser/Thr residues allow post-translational modification of Twist1 (illustrated
on the bottom).
While the Twist1 related mechanisms involved in the meso-
derm specification and the dorsal–ventral patterning during early
embryo development were extensively studied, the role of Twist1
in adult tissues is only beginning to be understood. The most
studied mechanisms are related to contribution of Twist1 to
tumorigenesis and invasiveness in epithelial cancers (Yang et al.,
2004; Kwok et al., 2005; Lee et al., 2006; Puisieux et al., 2006).
Also, several papers evidenced the role of Twist1 in chronic
inflammation and immunity (Sosic et al., 2003; Sharabi et al.,
2008; Doreau et al., 2009). The recent findings showing distinct
pattern of expression of Twist1 in various fat depots in mice
and humans (Pan et al., 2009; Pettersson et al., 2010a) as well
as correlation of Twist1 expression with BMI and insulin resis-
tance and AT inflammation (Pettersson et al., 2010b) are granting
future efforts towards understanding the specific Twist1 targets
and mechanisms employed for translational regulation in AT as
well as the functional relevance for pathologies such as insulin
resistance, type 2 diabetes and vascular disease.
Twist2 is also expressed in AT in mice and humans (Pan
et al., 2009; Pettersson et al., 2010b), however no depot-related
expressional difference was reported or any correlation with obe-
sity or insulin resistance (Pettersson et al., 2010b). Moreover,
Twist1 is selectively expressed in brown and white fat, while
Twist2 has a more ubiquitous expressional pattern (Pan et al.,
2009; Pettersson et al., 2010a). Therefore, in the remaining of the
review the focus will be on the evidence for presence and roles of
Twist1 in AT.
Twist1 EXPRESSION AND FUNCTIONAL ROLES
IN ADIPOSE TISSUE
AT is an endocrine organ characterized by significant plasticity
and cellular heterogeneity. Twist1 expression was reported for
both the white (Pettersson et al., 2010b) (WAT) and brown (Pan
et al., 2009) (BAT) ATs. Moreover, Twist1 was selectively expressed
in AT typically at levels over 10-fold higher than in other tis-
sues in adult rodents. Of the cells component of AT, white and
brown adipocytes express abundantly Twist1 (Pan et al., 2009;
Pettersson et al., 2010a). Also, endothelial cells, macrophages, and
T cells in WAT express Twist1 although mRNA expression is 2–3-
fold lower compared to adipocytes (Pettersson et al., 2010a). In
addition, Twist1 expression increases by 2-fold in pre-adipocytes
after 8 days of differentiation in culture conditions. Like other
developmental genes such as HoxA5, Tbx15, and Gpc4, Twist1
shows distinct pattern of expression in different adipose depots.
Expression of Twist1 is 6–8-fold higher in the subcutaneous (SAT)
vs. visceral (VAT) human AT (Pettersson et al., 2010b). The rea-
son for this expressional difference between the depots is not
known but suggests that Twist1 plays potentially important roles
in adipocyte development and fat distribution.
The unique developmental gene expression signature of the
different fat depots is largely independent of nutritional state,
at least in rodent models of obesity. Nonetheless, Twist1 gene
expression is highly correlated with BMI and is reduced in obesity
and increased following surgical or caloric restriction weight loss
in both SAT and VAT in humans (Pettersson et al., 2010b). Also,
Twist1 expression is negatively correlated with HOMA-IR and
adipocyte size in humans (Pettersson et al., 2010b). This obser-
vation does not directly support a causative relationship between
Twist1 and obesity and insulin resistance however strongly sug-
gests contribution of this gene to the pathogenesis of these
metabolic disorders.
In the following chapters the potential functional roles of
Twist1 in AT and contributing mechanisms to the pathogenesis
of obesity and insulin resistance will be discussed.
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Twist1 ANDWAT REMODELING IN OBESITY
AT is subjected to active remodeling throughout adult life.
Increased caloric intake leads to expansion of the tissue by up to
30-fold contributed by both the adipocyte number and hyper-
trophic remodeling (Sun et al., 2011). Conversely, with weight
loss, the size of the cells is reduced and pro-apoptotic mechanisms
and reduced adipocyte differentiation match the newly reduced
demand for substrate storage (Sethi and Vidal-Puig, 2007). The
capacity of AT to expand in response to excessive caloric intake
is depot specific and subject to inter-individual variation. It is
believed that 25–70% of the observed variability in BMI and
adipocyte number is genetically determined however the con-
tributing genes are not known (Nelson et al., 2000; Baker et al.,
2005).
The Twist1 gene is highly expressed in SAT vs. VAT and is
correlated with BMI (Pettersson et al., 2010b). Gene and pro-
tein expression is significantly decreased in both SAT and VAT
depots with obesity and increases with both surgical and caloric
restriction weight loss in humans (Pettersson et al., 2010b).
Interestingly, although Twist2 is also expressed in WAT there is
neither depot specific difference in the expression of the latter
nor any correlation with BMI (Pettersson et al., 2010b). This sug-
gests a potentially important role for Twist1, but not as much
for Twist2 in AT remodeling in adult life. Studies from Twist1
knockout mutants indicate that while the Twist1 homozygotes are
embryonically lethal due to increased apoptosis in multiple tis-
sues, the Twist2−/− homozygotes as well as Twist1+/−/Twist2+/−
compound heterozygote mice die within 7–15 days after birth
due to severe muscle wasting and systemic inflammation (Sosic
et al., 2003). Interestingly, the latter mutants are born with no
SAT and severely reduced VAT which explains the lethal cachexia.
This result suggests that Twist1 and 2 act redundantly to control
the formation of AT during embryogenesis. However, recent data
from Pan et al. demonstrate that Twist1 is not a contributor to
adipogenesis in either WAT or BAT in adult animals (Pan et al.,
2009).
AT remodeling in response to excess caloric intake involves
both hyperplastic and hypertrophic changes in the adipocytes.
These processes require both cell migration and extracellular
matrix remodeling. It is known that Twist1 plays an important
role in epithelial mesenchymal transition (EMT) in various forms
of malignant tumors and high levels of Twist1 are positively cor-
related with the metastatic potential (Martin and Cano, 2010;
Qin et al., 2012). Twist1 contributes to EMT by regulating path-
ways involved in cell migration, cadherin E and N expression,
and extracellular matrix remodeling, in particular of collagen
(Martin and Cano, 2010). Therefore, it is tempting to speculate
that Twist1 may play a role in cell migration and/or extracellular
matrix re-organization both of which are associated with active
AT remodeling (Lee et al., 2010). Interestingly, some evidence
points out towards the SAT as the first depot to respond to high
caloric intake by an increase in cell size and number (Arner et al.,
2010; Hoffstedt et al., 2010; Kursawe et al., 2010). Apparently
the adipocyte precursors are more readily mobilized in the SAT
and this may be controlled in part by the higher levels of Twist1
expression of SAT pre-adipocytes and adipocytes. However, direct
involvement of Twist1 in any of these processes is missing.
Also, the transcriptional mechanisms and Twist1 target genes
in different adipose depots are largely unknown. One recently
described mechanism by which Twist1 contributes to migration
of malignant cells is via downregulation of the miRNA let7i (Yang
et al., 2012). Interestingly, the let7 family of miRNAs, including
let7i was reportedly decreased in AT and adipocytes in obese vs.
lean humans (Arner et al., 2012). Whether, this is one of the
mechanisms by which Twist1 contributes to cell migration in
AT remains to be established. Also, expressional changes in sev-
eral collagen genes were reported as the second most prominent
change in SAT following profound fat loss in humans (Dankel
et al., 2010). In a rodent model of proliferative valvular heart dis-
ease, that over-expresses Twist1, several fibrillar collagens were
dysregulated and collagen 2a1 was identified as a direct tran-
scriptional target of Twist1 (Chakraborty et al., 2011). Therefore,
the direct role of Twist1 in matrix remodeling that accompa-
nies AT expansion in obesity is conceivable and is worth future
investigation.
ROLES OF Twist1 IN ADIPOCYTEMETABOLISM AND POTENTIAL
RELEVANCE FOR INSULIN RESISTANCE
Some direct and indirect recent evidence support a role for Twist1
in regulation of metabolism in the white and brown adipocytes.
In brown adipocytes Twist1 is a key orchestrator of PGC-1α tran-
scriptional regulation on target genes involved in uncoupling and
mitochondrial biogenesis (Pan et al., 2009). In an elegant study,
Pan et al. showed that PGC-1α physically interacts with Twist1 at
the N-terminal domain of the latter. This interaction takes place
at the promoter site of PGC1α target genes and results in recruit-
ment of HDAC5 which in turn inhibits gene expression of UCP1
and mCPT1. Also, PPARδ induces Twist1 expression upon ligand
activation but does not affect the basal Twist1 expression (Pan
et al., 2009). Therefore, it appears that Twist1 serves as a negative
feedback regulatory loop to finely tune PGC1α/PPARδ controlled
brown fat metabolism in response to nutrient status and to there-
fore ensure energy homeostasis (Figure 2A). Since a decrease of
energy expenditure was proposed to contribute to white fat accu-
mulation and obesity this study suggests that Twist1 may be a
positive indirect contributor to fat accumulation leading to obe-
sity. However, additional studies in human brown adipocytes are
critical to confirm this mechanism described in rodents and to
establish the potential contribution of Twist1 to regulation of
energy expenditure and obesity in humans.
In white human adipocytes, Twist1 also regulates fatty acid
oxidation (Pettersson et al., 2010a). Silencing of Twist1 using
siRNA determined decreased PGC1α and CPT1 expression along
with reduced fatty acid oxidation and no changes in genes con-
trolling basal lipolysis (Pettersson et al., 2010a) (Figure 2A).
This result suggests that Twist1 is a promoter of fatty acid oxi-
dation in white adipocytes arguing for a potentially beneficial
metabolic effect. The detailed transcriptional mechanisms were
not described in the white adipocytes. It is possible that other
bHLH transcription factors present in adipocytes, such as the
id class of proteins by binding to E-box proteins such as, E12
or E47, sequester the latter therefore preventing them to het-
erodimerize with Twist1. In effect, Twist1 may form preferentially
homodimers which may have opposite transcriptional effects
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FIGURE 2 | (A) Twist1 transcriptional effects in white (Thisse et al., 1987)
and brown (Thisse et al., 1988) adipocytes. 1. In white human adipocytes
Twist1 participates in basic transcription of TNFα and IL6, possibly by direct
binding to their Ebox consensus sequences; however, increased formation
of TNFα, up-regulates Twist which in turn will bind to p65 and prevent
trans-activation of the TNFα and IL6 genes by the active NFkB complex;
also, Twist increase expression attenuates the effect of TNFα on MCP-1
production; by participating in this negative feedback loop, Twist1 may limit
inflammation in white adipocytes; Twis-1 also has metabolic effects by
direct binding to PGC1α (PPARγ co-activator 1) which in turn increases
fatty acid oxidation. 2. In mouse brown adipocytes Twist1 is up-regulated
by PPARδ; Twist1 binding to PGC1α promotes recruitment of HDAC5 at
the promoter of the target genes UCP1 (uncoupling protein 1) and CPT1
(carnitine palmitolyl transferase 1) which results in reduced brown fat
energy dissipation. (B) Pathways modulated by Twist1 leading to potentially
improved insulin resistance in obesity. Excess nutrient excess and obesity
leads to adipocyte inflammation, immune cell recruitment in adipose tissue
and hypertrophic and hyperplastic remodeling of AT. Inflamed adipocytes
secrete pro-inflammatory cytokines (TNFα, IL6, etc.) which via NFkB and
STAT3 lead to formation of chemokines including MCP1 (macrophage
attractant protein 1) that further exacerbate tissue inflammation. Twist1 is
activated by TNFα and acts via a negative regulatory loop at the level of
NKkB to limit formation of pro-inflammatory cytokines and chemokines;
the macrophages infiltrating adipose tissue in obesity are a rich source of
IL12 which induces Th1 polarization of T cells and via STAT4 and Tbet
induces formation of IFNγ; Twist1 is also up-regulated by IL12/STAT4; Twist
may bind to Runx3 and prevent the latter to interact with Tbet therefore
reducing IFNγ transcription; by limiting the pro-inflammatory effects of
IL12, Twist1 further prevents local inflammation; active expansion of
adipose tissue in obesity may not be matched by adequate angiogenesis;
local hypoxia activates HIF1α and HIF2α (hypoxia-inducible factors) which
can directly bind and up-regulate Twist1 expression; Twist1 in turn may
promote formation of VEGFA that induces angiogenesis and restores the
adequate oxygen and nutrient demand of the adipose tissue leading to
“healthy” remodeling. Collectively, these pathways modulated by Twist1
may lead to prevention of insulin resistance in obesity.
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on target genes compared to Twist1/E-box heterodimers. An
interesting observation is that both id1 and id3 knockout mice
are protected from obesity induced insulin resistance and AT
inflammation (Akerfeldt and Laybutt, 2011; Cutchins et al., 2011;
Satyanarayana et al., 2012). One may therefore speculate that lack
of id3 proteins could facilitate formation of Twist1 heterodimers
with E-box partners and exert a positive effect on AT insulin
sensitivity.
Twist1 AS POTENTIAL REGULATOR OF INFLAMMATION
IN ADIPOSE TISSUE
Ample evidence suggests that VAT inflammation provides a
mechanistic link between obesity and insulin resistance (de
Luca and Olefsky, 2008). Preferential immune infiltration and
increased pro-inflammatory cytokine production by both the
adipocytes and granulocytes/lymphocytes in VAT compared to
SAT was described in both murine models and in human obe-
sity (Dobrian et al., 2010; Lumeng and Saltiel, 2011; Morris et al.,
2011). The reasons for depot-specific differences in inflamma-
tion are incompletely understood. Since Twist1 is differentially
expressed in the VAT and SAT and inversely correlated with BMI
it is possible that Twist1 may have anti-inflammatory effects that
are more prominent in SAT compared to VAT and may account
in part for the differences in inflammation between the two
depots.
Twist1 is expressed in T cells, macrophages, dendritic cells, and
natural killer cells (Franco et al., 2010). Twist1 and 2 proteins
were found to perform important roles in lymphocyte function
and maturation. In Th1 cells Twist1 is induced by NFkB and as
a result of IL12/STAT4 signaling (Sosic et al., 2003; Sharif et al.,
2006). Twist1 induced expression in turn reduces production of
IFNγ and TNFα, therefore, preventing their pro-inflammatory
action in the context of chronic inflammation (Niesner et al.,
2008). Similarly, in macrophages, IFNγ induces Twist1 expres-
sion which, in turn, reduces TNFα production (Sharif et al.,
2006). The reduction of pro-inflammatory cytokine production
is achieved via a negative feedback regulatory loop at the level
of NFkB. It was demonstrated that Twist1 and 2 both physi-
cally interact with NFkB, in an evolutionary conserved fashion,
leading to inhibition of p65 and repression of NFkB transac-
tivation of cytokines gene promoters (Sosic et al., 2003). The
importance of this negative feedback loop was demonstrated
by the phenotype of twist1+/−/twist2+/− mice that die peri-
nataly due to severe systemic inflammation and cachexia. A
recent paper elegantly showed that in Th1 cells, Twist1 neg-
atively regulates expression and function of key transcription
factors such as, T-bet, STAT4, and Runx3 (Pham et al., 2012).
One of the mechanisms by which Twist1 limits IFNγ produc-
tion in Th1 cells is by physical interaction with Runx3 that
prevents association of the latter with T-bet at the Ifng locus
(Pham et al., 2012). These seemingly common mechanisms of
action of Twist1 in various immune cells result in a reduc-
tion of pro-inflammatory cytokine production. Since all of these
immune cells infiltrate AT in obesity and contribute to local
inflammation selectively in the VAT, (Lumeng and Saltiel, 2011)
it is conceivable to hypothesize that increased Twist1 expres-
sion in SAT contributes to limiting inflammation in this depot;
a decrease of Twist1 expression in AT in obesity suggests that
the pro-inflammatory cytokine feedback inhibition by Twist1 is
impaired and may account for the exacerbation of inflammation
(Figure 2B).
Twist1 also affects cytokine production in white adipocytes in
humans (Pettersson et al., 2010a). Apparently, Twist1 is required
for the basal transcription of IL6, TNFα, and MCP-1 possibly via
direct interaction, as all of these genes contain E-boxes in their
gene promoters (Pettersson et al., 2010a). However, in a pro-
inflammatory setting, when TNFα is increased, the presence of
Twist de-sensitizes the effects of TNFα on MCP1 mRNA expres-
sion and secretion (Pettersson et al., 2010b) (Figure 2A). This
is achieved in part by a reduction of at least two important
components in the TNFα signaling pathway: RelA and TNF-
R1 (Pettersson et al., 2010b). This suggests that Twist1 could
have different effects in AT depending upon the local milieu.
Interestingly, Twist1 expression is also inversely associated with
adipocyte size and HOMA-IR in obese humans suggesting a
possible role in insulin sensitivity (Pettersson et al., 2010b).
Adiponectin is a cytokine produced exclusively in AT with anti-
inflammatory and insulin sensitizing roles (Turer and Scherer,
2012). Adiponectin expression correlated strongly and positively
with Twist1 expression in SAT of obese subjects (Pettersson
et al., 2010b). However, in isolated adipocytes, Twist1 silenc-
ing did not affect adiponectin levels (Pettersson et al., 2010a).
This finding suggests that is unlikely that there might be a direct
link between the two proteins. One can speculate that an indi-
rect link may be via the id3/E47 interaction. Adiponectin gene
transcription can be repressed by id3 which interacts with E47
thereby preventing SREBP-1c mediated trans-activation of the
adiponectin gene (Doran et al., 2008). One possible explana-
tion is that in inflammatory conditions when id3 expression is
increased the latter may exert an inhibitory effect on adiponectin
transcription and, conversely high levels of Twist1 may outcom-
pete id3 in interaction with E47 and therefore could limit the
id3 inhibitory effect. Additional studies are key to understand the
mechanisms involved in regulation of adiponectin transcription
by Twist1.
Collectively, this data suggests that Twist1 could limit inflam-
mation in AT via effects on adipocytes and on the immune cells
infiltrating the AT (Figure 2B).
REGULATION OF Twist1 BY HYPOXIA AND IMPLICATIONS FOR
ANGIOGENESIS IN ADIPOSE TISSUE REMODELING IN OBESITY
The unique plasticity of AT in response to caloric intake ensures
proper energy homeostasis. Expansion of AT requires ade-
quate recruitment of adipocytes, and matching nutrient and O2
demands provided by adequate vasculature (Rutkowski et al.,
2009). The failure to mount an adequate hyperplastic and angio-
genic response leads to adipocyte hypertrophy, hypoxia and
subsequent inflammation, and fibrosis that may ultimately con-
tribute to the onset of insulin resistance (Hosogai et al., 2007;
Pasarica et al., 2009; Spencer et al., 2011). Numerous evidence
shows that in most but not in all cases obesity is accompanied by
the “unhealthy” remodeling of AT (Sun et al., 2011). One of the
major contributors is impaired angiogenesis, with the subsequent
hypoxia, inflammation and fibrosis.
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Twist1 is regulated at transcriptional level by both HIF1α and
HIF2α in response to a hypoxic stimulus. HIF1α regulates Twist1
by direct binding to the hypoxia-response element in its promoter
(Yang et al., 2008) while HIF2α binds at the level of intronic
hypoxia response elements in the Twist1 gene (Gort et al., 2008).
Up-regulation of Twist1 by the HIF proteins in highly hypoxic
tumors is considered key for the EMT and tumor metastasis (Yang
et al., 2008). Also, Twist1 was showed to induce angiogenesis
in hepatocellular carcinomas (Niu et al., 2007) and was corre-
lated with VEGF expression in breast cancer tumors (Mironchik
et al., 2005). There is no evidence for a direct angiogenic role
of Twist1 in AT in response to hypoxia or for the downstream
molecular targets, but it is tempting to propose that high levels
of Twist1 expression may promote angiogenesis in a fast growing
AT therefore contributing to healthy remodeling of AT in obesity
(Figure 2B).
CONCLUSION
Recent findings showed unexpected and complex roles for devel-
opmental transcription factors in adult tissues undergoing active
remodeling, such as, solid tumors and AT and relationships
with pathogenesis of cancer and metabolic diseases. The poten-
tial involvement of Twist1 in AT metabolism, inflammation, and
remodeling grants future research to unravel the molecular tar-
gets and transcriptional programs involved. Understanding the
complex regulation of Twist1 in cells component of AT ultimately
can generate new therapies to control AT healthy remodeling in
response to nutritional challenges.
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